ClinicalTrials.gov
ClinicalTrials.gov Menu

Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00068146
Recruitment Status : Completed
First Posted : September 9, 2003
Last Update Posted : October 6, 2017
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)